These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiproliferative effect of the somatostatin analogue octreotide on growth hormone-producing pituitary tumors: results of a multicenter randomized trial. Thapar K; Kovacs KT; Stefaneanu L; Scheithauer BW; Horvath E; Lloyd RV; Li J; Laws ER Mayo Clin Proc; 1997 Oct; 72(10):893-900. PubMed ID: 9379690 [TBL] [Abstract][Full Text] [Related]
4. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337 [TBL] [Abstract][Full Text] [Related]
5. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Plöckinger U; Quabbe HJ Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Amato G; Mazziotti G; Rotondi M; Iorio S; Doga M; Sorvillo F; Manganella G; Di Salle F; Giustina A; Carella C Clin Endocrinol (Oxf); 2002 Jan; 56(1):65-71. PubMed ID: 11849248 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effect of octreotide in somatotroph pituitary adenomas: discussion from a single case report. Delgrange E; Trouillas J; Gustin T; Gilliard C; Donckier JE Acta Neurochir (Wien); 2001; 143(7):733-6. PubMed ID: 11534696 [TBL] [Abstract][Full Text] [Related]
8. Management of a pregnant woman with thyrotropinoma: a case report and review of the literature. Perdomo CM; Árabe JA; Idoate MÁ; Galofré JC Gynecol Endocrinol; 2017 Mar; 33(3):188-192. PubMed ID: 27910710 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas. Colao A; Filippella M; Di Somma C; Manzi S; Rota F; Pivonello R; Gaccione M; De Rosa M; Lombardi G Endocrine; 2003 Apr; 20(3):279-83. PubMed ID: 12721508 [TBL] [Abstract][Full Text] [Related]
10. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature. Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085 [TBL] [Abstract][Full Text] [Related]
11. [The role of somatostatin analogues in the treatment of hypophyseal adenomas]. Losa M; Mortini P; Giovanelli M Minerva Endocrinol; 2003 Mar; 28(1):39-51. PubMed ID: 12621362 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin analogs in the treatment of acromegaly. Lamberts SW; Reubi JC; Krenning EP Endocrinol Metab Clin North Am; 1992 Sep; 21(3):737-52. PubMed ID: 1355729 [TBL] [Abstract][Full Text] [Related]